Jump to content

Linsidomine

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Dexbot (talk | contribs) at 23:36, 27 August 2015 (Bot: Deprecating Template:Cite pmid and some minor fixations). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Linsidomine
Clinical data
Other namesSIN-1
AHFS/Drugs.comInternational Drug Names
ATC code
Identifiers
  • 5-imino-3-morpholin-4-yl-5H-1,2,3-oxadiazol-3-ium-2-ide
PubChem CID
ChemSpider
UNII
KEGG
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC6H10N4O2
Molar mass170.17 g/mol g·mol−1
3D model (JSmol)
  • C1COCCN1[N+]2=NOC(=C2)[NH-]
  • InChI=1S/C6H10N4O2/c7-6-5-10(8-12-6)9-1-3-11-4-2-9/h5,7H,1-4H2
  • Key:FKDHHVKWGRFRTG-UHFFFAOYSA-N
  (verify)

Linsidomine (3-morpholinosydnonimine or SIN-1[1]) is a vasodilator. It is a metabolite of the antianginal drug molsidomine and acts by releasing NO from the endothelial cells nonenzymatically. It also hyperpolarizes the cell membrane through influencing the sodium-potassium pump and thereby rendering it less responsive to adrenergic stimulation. Linsidomine injection at a dose of 1 mg produces usable erection[2] in about 70% of patients and full erection in up to 50% of patients. Linsidomine does not appear to be associated with priapism.[citation needed]

Linsidomine is neurotoxic and promotes oxidative stress on neurons.[3] Linsidomine is a peroxynitrite-generating compound involved in the pathogenesis of neurodegenerative diseases.[4]

References

  1. ^ Wen, TC.; Rogido, MR.; Moore, JE.; Genetta, T.; Peng, H.; Sola, A. (Oct 2005). "Cardiotrophin-1 protects cortical neuronal cells against free radical-induced injuries in vitro". Neurosci Lett. 387 (1): 38–42. doi:10.1016/j.neulet.2005.07.018. PMID 16084018.
  2. ^ Lemaire, A.; Buvat, J. (1998). "Erectile response to intracavernous injection of linsidomine in 38 impotent patients. Comparison with prostaglandin E1". Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie. 8 (3): 388–391. PMID 9689672.
  3. ^ Wallace, DR.; Dodson, S.; Nath, A.; Booze, RM. (Jan 2006). "Estrogen attenuates gp120- and tat1-72-induced oxidative stress and prevents loss of dopamine transporter function". Synapse. 59 (1): 51–60. doi:10.1002/syn.20214. PMID 16237680.
  4. ^ Jang, JH.; Aruoma, OI.; Jen, LS.; Chung, HY.; Surh, YJ. (Feb 2004). "Ergothioneine rescues PC12 cells from beta-amyloid-induced apoptotic death". Free Radic Biol Med. 36 (3): 288–99. doi:10.1016/j.freeradbiomed.2003.11.005. PMID 15036348.